Atorvastatin neutralizes the up-regulation of thrombospondin-1 induced by thrombin in human umbilical vein endothelial cells

Endothelium: Journal of Endothelial Cell Research

Volumn 14, Issue 4-5, 2007, Pages 233-238

  Martínez Sales, Vicenta ^a   Vila, Virtudes ^a   Ferrando, Marcos ^a   Reganon, Edelmiro ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Atorvastatin; Endothelial Cells; Thrombin; Thrombospondin 1

Indexed keywords

ATORVASTATIN; FARNESYL DIPHOSPHATE; FARNESYL DIPHOSPHATE INHIBITOR; GERANYLGERANYL PYROPHOSPHATE; GERANYLGERANYL PYROPHOSPHATE INHIBITOR; GGTI 298; MEVALONIC ACID; N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE METHYL ESTER; RHO KINASE INHIBITOR; THROMBIN; THROMBOSPONDIN 1; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC ANALYSIS; GENETIC REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; UMBILICAL VEIN; UPREGULATION;

BENZAMIDES; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME INHIBITORS; HEPTANOIC ACIDS; HUMANS; METHIONINE; MEVALONIC ACID; POLYISOPRENYL PHOSPHATES; PYRROLES; RHO-ASSOCIATED KINASES; SESQUITERPENES; THROMBIN; THROMBOSPONDIN 1; UMBILICAL VEINS; UP-REGULATION;

EID: 35148861181     PISSN: 10623329     EISSN: 10292373     Source Type: Journal    
DOI: 10.1080/10623320701617209     Document Type: Article

References (29)

1. Baenziger, N. L., Brodie, G. N. and Majerus, P. W. (1971) A thrombin-sensitive protein of human platelet membranes. Proceedings of the National Academy of Sciences of the United States of America, 68, pp. 240-243.
2. Boerman, M., Burton, G. R., Wang, J., Fink, L. M., McGehee, R. E. and Hauer-Jensen, M. (2006) Comparative expression profiling in primary and immortalized endothelial cells: Changes in gene expression in response to hydroxy methylglutaryl-coenzyme A reductase inhibition. Blood Coagulation and Fibrinolysis, 17, pp. 173-180.
3. Bonnefoy, A., Hantgan, R., Legrand, C. and Frojmovic, M. M. (2001) A model of platelet aggregation involving multiple interactions of thrombospondin-1, fibrinogen, and GPIIbIIIa receptor. The Journal of Biological Chemistry, 276, pp. 5605-5612.
4. Coughlin, S. R. (2000) Thrombin signalling and protease-activated receptors. Nature, 407, pp. 258-264.
5. Dulak, J., Loboda, A., Jazwa, A., Zagorska, A., Dörler, J., Alber, H., Dichtl, W., Weidinger, F., Frick, M. and Jozkowicz, A. (2005) Atorvastatin affects several angiogenic mediators in human endothelial cells. Endothelium, 12, pp. 233-241.
6. Edwards, P. A. and Ericsson, J. (1999) Sterols and isoprenoids: Signaling molecules derived from the cholesterol biosynthetic pathway. Annual Reviews of Biochemistry, 68, pp. 157-185.
7. Esemuede, N., Lee, T., Pierre-Paul, D., Sumpio, B. E. and Gahtan, V. (2004) The role of thrombospondin-1 in human disease. Journal of Surgical Research, 122, pp. 135-142.
8. Eto, M. and Luscher, T. F. (2003) Modulation of coagulation and fibrinolytic pathways by statins. Endothelium, 10, pp. 35-41.
9. Iruela-Arispe, M. L., Luque, A. and Lee, N. (2004) Thrombospondin modules and angiogenesis. The International Journal of Biochemistry and Cell Biology, 36, pp. 1070-1078.
10. Jurk, K., Clemetson, K. J., de Goot, P. G., Brodde, M. F., Steiner, M., Savion, N., Varon, D., Sixma, J. J., Van Aken, H. and Kehrel, B. E. (2003) Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): An alternative/backup mechanism to von Willebrand factor. The FASEB Journal, 17, pp. 1490-1492.
11. Kaushal, V., Kohli, M., Mehta, P. and Mehta, J. L. (2003) Potential anticancer effects of statins: Fact or fiction?. Endothelium, 10, pp. 49-58.
12. Lawler, J., Sunday, M., Thibert, V., Duquette, M., George, E. L., Rayburn, H. and Hynes, R. O. (1998) Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. The Journal of Clinical Investigation, 101, pp. 982-992.
13. Liao, J. K. and Laufs, U. (2005) Pleiotropic effects of statins. Annual Reviews of Pharmacology and Toxicology, 45, pp. 89-118.
14. Loboda, A., Agnieszka, J., Jozkowicz, A., Molema, G. and Dulak, J. (2006) Angiogenic transcriptome of human microvascular endothelial cells: Effect of hypoxia, modulation by atorvastatin. Vascular Pharmacology, 44, pp. 206-214.
15. Martínez-Sales, V., Gomez-Lechón, M. J. and Gilabert, J. (1990) Characteristics of arachidonic acid metabolism of human endothelial cells in culture. Cytotechnology, 3, pp. 21-29.
16. McLaughlin, J. N., Mazzoni, M. R., Cleator, J. H., Earls, L., Perigoto, A. L., Brooks, J. D., Muldowney, J. A. S., Vaughan, D. E. and Hamm, H. E. (2005) Thrombin modulates the expression of a set of genes including thrombospondin-1 in human microvascular endothelial cells. The Journal of Biological Chemistry, 280, pp. 22172-22180.
17. Ohkawara, H., Ishibashi, T., Sakamoto, T., Sugimoto, K., Nagata, K., Yokoyama, K., Sakamoto, N., Kamioka, M., Matsuoka, I., Fukuhara, S., Sugimoto, N., Takuwa, Y. and Maruyama, Y. (2005) Thrombin-induced rapid geranyl geranylation of RhoA as an essential process for RhoA activation in endothelial cells. The Journal of Biological Chemistry, 280, pp. 10182-10188.
18. Park, H. J., Kong, D., Iruela-Arispe, M. L., Begley, U., Tang, D. and Galper, J. B. (2002) 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Circulation Research, 91, pp. 143-150.
19. Reed, M. J., Puolakkainen, P., Lane, T. F., Dickerson, D., Bronstein, P. and Sage, E. H. (1993) Differential expression of SPARC and thrombospondin 1 in wound repair: Immunolocalization and in situ hybridization. Journal of Histochemistry and Cytochemistry, 41, pp. 1467-1477.
20. Riewald, M. and Ruf, W. (2005) Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signalling. The Journal of Biological Chemistry, 280, pp. 19808-19814.
21. Sargiannidou, I., Qiu, C. and Tuszynski, G. P. (2004) Mechanisms of thrombospondin-1-mediated metastasis and angiogenesis. Seminars in Thrombosis Hemostasis, 30, pp. 127-136.
22. Skaletz-Rorowski, A. and Walsh, K. (2003) Statin therapy and angiogenesis. Current Opinion in Lipidology, 14, pp. 599-603.
23. Tesfamariam, B. (2006) The effects of HMG-CoA reductase inhibitors on endothelial cells. American Journal of Cardiovascular Drugs, 6, pp. 115-120.
24. Tolsma, S. S., Stack, M. S. and Bouck, N. (1997) Lumen formation and other angiogenic activities of cultured capillary endothelial cells are inhibited by thrombospondin-1. Microvascular Research, 54, pp. 13-26.
25. Tong, H., Holstein, S. A. and Hohl, R. J. (2005) Simultaneous determination of farnesyl and geranyl pyrophosphate levels in culture cells. Analytical Biochemistry, 336, pp. 51-59.
26. Trumel, C., Plantavid, M., Levy-Toledano, S., Ragab, A., Coen, J. P., Aguado, E., Malissen, B. and Payrastre, B. (2003) Platelet aggregation induced by the C-terminal peptide of thrombospondin-1 requires the docking protein LAT but is largely independent of alphaIIb/beta3. Journal of Thrombosis and Haemostasis, 1, pp. 320-329.
27. Urbich, C., Dernbach, E., Zeiher, A. M. and Dimmeler, S. (2002) Double-edged role of statins in angiogenesis signaling. Circulation Research, 90, pp. 737-744.
28. Uzony, B., Lötzer, K., Jahn, S., Kramer, C., Hildner, M., Bretschneider, E., Radke, D., Beer, M., Vollandt, R., Evans, J. F., Funk, C. D. and Habenicht, A. J. R. (2006) Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in endothelial cells. Proceedings of the National Academy of Sciences of the United States of America, 103, pp. 6326-6331.
29. Weis, M., Heeschen, C., Glassford, A. J. and Cooke, J. P. (2002) Statins have biphasic effects on angiogenesis. Circulation, 105, pp. 739-745.